asparlas 750 U/mL
calaspargase pegol · INJECTION, SOLUTION · Servier Pharmaceuticals LLC
Asparlas is an asparagine-specific enzyme given by intravenous injection used to treat certain types of leukemia and lymphoma in patients who cannot tolerate other asparaginase medications. It works by depleting asparagine, an amino acid that leukemia and lymphoma cells need to survive.
Key Facts
- Brand Name
- asparlas
- Generic Name
- calaspargase pegol
- NDC Code (Product)
72694-515- Manufacturer
- Servier Pharmaceuticals LLC
- Strength
- 750 U/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761102
- Drug Class
- Asparagine-specific Enzyme [EPC]
- Marketing Start
- 09/27/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is asparlas used for?
Asparlas is an asparagine-specific enzyme given by intravenous injection used to treat certain types of leukemia and lymphoma in patients who cannot tolerate other asparaginase medications. It works by depleting asparagine, an amino acid that leukemia and lymphoma cells need to survive.
Is asparlas a controlled substance?
asparlas is not classified as a controlled substance by the DEA.
What is the generic name for asparlas?
The generic name for asparlas is calaspargase pegol. There are no other listed brand versions of calaspargase pegol.
What is the NDC code for asparlas 750 U/mL?
The NDC (National Drug Code) for asparlas 750 U/mL is 72694-515, listed by Servier Pharmaceuticals LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)